Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
Biological Psychiatry|August 23, 2020
Dysregulation of Decision Making Related to Metabotropic Glutamate 5, but Not Midbrain D<sub>3</sub>, Receptor Availability Following Cocaine Self-administration in RatsStephanie M Groman, Ansel T Hillmer, Heather Liu, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 8, 2015
Reference region modeling approaches for amphetamine challenge studies with [11C]FLB 457 and PETChristine M Sandiego, Jean-Dominique Gallezot, Keunpoong Lim, et al.Alcoholism, Clinical and Experimental Research|November 4, 2008
When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamineKarmen K Yoder, Evan D Morris, Cristian C Constantinescu, et al.Alcoholism, Clinical and Experimental Research|April 13, 2007
Heterogeneous effects of alcohol on dopamine release in the striatum: a PET studyKarmen K Yoder, Cristian C Constantinescu, David A Kareken, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 7, 2026
Receptor subtype distribution from PET occupancy studies: Novel analysis of maximum occupancy images using a selective drug and a non-selective tracerSu Jin Kim, Alaaddin Ibrahimy, Cristian C Constantinescu, et al.American Journal of Nuclear Medicine and Molecular Imaging|September 21, 2016
PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivoAishwarya Vijay, Shuo Wang, Patrick Worhunsky, et al.Molecular Imaging|November 16, 2005
ntPET: a new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter releaseEvan D Morris, Karmen K Yoder, Chunzhi Wang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2013
Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkeySu Jin Kim, Ming-Qiang Zheng, Nabeel Nabulsi, et al.Neoplasia (New York, N.Y.)|January 10, 2014
Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domainJ Ryan Petrulli, Jenna M Sullivan, Ming-Qiang Zheng, et al.Alcoholism, Clinical and Experimental Research|June 25, 2005
Dopamine D(2) receptor availability is associated with subjective responses to alcoholKarmen K Yoder, David A Kareken, Regat A Seyoum, et al.Pageof 8